Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-005186-73Phase 4Completed
Phase 4, open-label, single-arm trial of methylprednisolone, methylprednisolone sodium succinate and hydrocortisone butyrate, sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Urine concentration of glucocorticoids. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-005186-73.